Lilly locks in 5-program R&D pact with China’s Haisco worth up to $3B, but targets unclear - Fierce Biotech
Lilly locks in 5-program R&D pact with China’s Haisco worth up to $3B, but targets unclear Fierce Biotech
Lilly locks in 5-program R&D pact with China’s Haisco worth up to $3B, but targets unclear Fierce Biotech